Neuromodulation for treatment-refractory major depressive disorder
نویسندگان
چکیده
منابع مشابه
Neuromodulation for treatment-refractory major depressive disorder.
ajor depressive disorder is among the most prevalent psychiatric disorders and is a leading cause of morbidity and lost productivity. 1 The 1-year prevalence of major depressive disorder in the Canadian population is 3.2%–4.6%. 2 A large, multisite prospective trial showed that only 28% of patients ex-peri ence remission following monotherapy with a serotonin reuptake inhibitor. 3 Further, remi...
متن کاملVortioxetine versus placebo for treatment of major depressive disorder
Introduction: Major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. Approved by the FDA in September 2013 for treatment of episodes of major depressive disorder, Vortioxetine is one of the newer options available in this important area of therapeutics. Materials and methods: A comprehensive literature search (PubMed, the Cochrane libr...
متن کاملNeuromodulation Treatments in Clinical Practice: Should TMS Be Used for the Treatment of Major Depressive Disorder?
In the past decade, advances in science have produced several novel neuromodulation therapies. As novel neuromodulation therapies are introduced, it is imperative that clinicians in the field of Psychology and Psychiatry carefully weigh the evidence base, risks and benefits before applying these new treatments to our patients Neuromodulation therapies that have emerged include: (1) Transcranial...
متن کاملvortioxetine versus placebo for treatment of major depressive disorder
introduction: major depressive disorder is a common mental condition associated with substantial morbidity and economic burden. approved by the fda in september 2013 for treatment of episodes of major depressive disorder, vortioxetine is one of the newer options available in this important area of therapeutics. materials and methods: a comprehensive literature search (pubmed, the cochrane libra...
متن کاملSheehan’s Syndrome Presenting as Major Depressive Disorder
Sheehan’s syndrome or Simmond’s disease is a rare endocrine disorder seen in clinical practice. The clinical spectrum is diverse and a high index of suspicion together with a good clinical acumen and proper diagnostic approach helps in early diagnosis and prompt treatment of this endocrinopathy. Sheehan’s syndrome presenting as a major depressive disorder finds less mention in the literature.Th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2013
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.121317